Optic Neuritis News and Research

RSS
Optic neuritis is a condition in which the optic nerve becomes inflamed and swollen, leading to an acute severe impairment of vision in the affected eye. The swelling may further lead to damage to the nerve fibers running through the nerve, causing permanent or temporary loss of vision in that eye. It is much more common in young female patients.
Researchers find possible causes for lacking of effective therapy for multiple sclerosis

Researchers find possible causes for lacking of effective therapy for multiple sclerosis

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Popular allergy drug may reduce relapses in patients with neuromyelitis optica

Popular allergy drug may reduce relapses in patients with neuromyelitis optica

Updated ‘McDonald Criteria’ expected to improve speed and accuracy of MS diagnosis

Updated ‘McDonald Criteria’ expected to improve speed and accuracy of MS diagnosis

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

New therapeutic agent shows potential for treating optic neuritis linked to multiple sclerosis

New therapeutic agent shows potential for treating optic neuritis linked to multiple sclerosis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Color-deficiency or color-blindness?

Color-deficiency or color-blindness?

Common antihistamine may partially reverse damage to visual system in multiple sclerosis patients

Common antihistamine may partially reverse damage to visual system in multiple sclerosis patients

Retinal thickness points to disability worsening in MS patients

Retinal thickness points to disability worsening in MS patients

Taste deficits appear to be more prevalent in MS patients

Taste deficits appear to be more prevalent in MS patients

Neuroprotection powers for phenytoin in acute optic neuritis

Neuroprotection powers for phenytoin in acute optic neuritis

Escalation therapy for neuromyelitis attacks improves remission rates

Escalation therapy for neuromyelitis attacks improves remission rates

Multiple sclerosis relapse management: an interview with Gina Remington

Multiple sclerosis relapse management: an interview with Gina Remington

Children recover well from acute central nervous system demyelination

Children recover well from acute central nervous system demyelination

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015